Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Keiji Hirata
Institution:
University of Occupational and Environmental Health Japan
Observed institution:
University of Occupational and Environmental Health Japan
ORCID:
0000-0001-6461-5109
Observed ORCID:
0000-0001-6461-5109
OpenAlex ID:
A5122783400
Post-adjuvant chemotherapy in ctDNA-positive patients with resected colorectal cancer: a randomized phase 3 trial
2026
·
Hideaki Bando
, Jun Watanabe
, et al.
·
Nature Medicine
·
25
PDF
Gastric Outlet Obstruction Caused by Adhesion Between Remnant Greater Omentum and Lesser Omentum After Laparoscopic Transverse Colectomy
2026
·
Kyosuke Yoshitake
, Jun Nagata
, et al.
·
Asian Journal of Endoscopic Surgery
·
2
PDF
Potential of green tea extract to suppress colorectal polyp development in patients with familial adenomatous polyposis: a double-blind, randomized controlled trial Japan Familial Adenomatous Polyposis Prevention Study (J-FAPP Study I)
2026
·
Hideki Ishikawa
, Michihiro Mutoh
, et al.
·
Genes and Environment
·
1
Post-hoc central radiological review of the ALTAIR study in patients with molecular residual disease (MRD) following curative resection of colorectal cancer (CRC).
2026
·
Jun Watanabe
, Hideaki Bando
, et al.
·
Journal of Clinical Oncology
·
1
PDF
Robot-Assisted Ileocecal Resection for Cecal Cancer with a Common Trunk of the Middle Colic and Ileocolic Arteries: A Case Report
2026
·
Yasuki Akiyama
, Kei Nakada
, et al.
·
Surgical Case Reports
·
1
PDF
Clinical significance of WES-defined ERBB2 amplification in resectable colorectal cancer
2026
·
Kazuki Kishi
, Atsushi Hamabe
, et al.
·
International Journal of Clinical Oncology
PDF
A multicenter survey on BRAF screening for the implementation of perioperative cancer genomic medicine for resectable colorectal oligometastases
2026
·
Shin Kobayashi
, Nobuhisa Matsuhashi
, et al.
·
International Journal of Clinical Oncology
Comparison of longitudinal circulating tumor DNA (ctDNA) and carcinoembryonic antigen (CEA) for post-operative risk stratification in colorectal cancer (CRC).
2026
·
Eiji Oki
, Koji Ando
, et al.
·
Journal of Clinical Oncology
PDF
Benefit of adjuvant chemotherapy in resected stage I-IV CRC patients based on ctDNA dynamics across two timepoints: Results from GALAXY study.
2026
·
Mitsuru Yokota
, Hideaki Bando
, et al.
·
Journal of Clinical Oncology
Impact of postsurgical circulating tumor DNA (ctDNA) dynamics on eligibility of colorectal cancer (CRC) patients for randomized ALTAIR trial: Implications for treat-on-molecular-recurrence (TOMR) trials.
2026
·
Hideaki Bando
, Yoshiaki Nakamura
, et al.
·
Journal of Clinical Oncology
Correlation of presurgical circulating tumor DNA (ctDNA) levels with pathologic (p) stage and lymph node (LN) burden in localized colon cancer.
2026
·
Masahito Kotaka
, Hideaki Bando
, et al.
·
Journal of Clinical Oncology
Clinical Impact of Baseline ctDNA RAS/BRAF Mutations on Conversion Surgery and Outcomes in First-Line Anti-EGFR Therapy for Advanced Colorectal Cancer
2026
·
Takeshi Yamada
, Takeshi Nagasaka
, et al.
·
Cancers
A Case of Granulocyte Colony-stimulating Factor-producing Adenosquamous Carcinoma of the Ascending Colon
2026
·
Masahiro Takeuchi
, Yoshikazu Harada
, et al.
·
Journal of the Anus Rectum and Colon
PDF
Impact of postoperative ctDNA dynamics on eligibility for the ALTAIR randomized trial in patients with colorectal cancer: Implications for clinical trial enrollment.
2026
·
Yoshiaki Nakamura
, Hideaki Bando
, et al.
·
Journal of Clinical Oncology
Prognostic value of presurgical circulating tumor DNA (ctDNA) levels and other clinical factors in colon cancer.
2026
·
Naoya Akazawa
, Saori Mishima
, et al.
·
Journal of Clinical Oncology
PDF
Assessing adjuvant chemotherapy benefit in younger and older molecular residual disease–positive patients with stage II/III colorectal cancer.
2026
·
Saori Mishima
, Koji Ando
, et al.
·
Journal of Clinical Oncology
Show more works
View as search
Works count:
16
Citation count:
30
H-index:
2
I10-index:
1
Year
Topic
Type